NLC India Ltd. - Research Center
513683 NLCINDIA Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 22 | Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | |
|---|---|---|---|---|---|
| Sales | 2,752.75 | 3,094.46 | 2,579.26 | 2,423.59 | 2,493.67 |
| Operating profit | 998.06 | 1,373.67 | 872.58 | 818.57 | 994.87 |
| Interest | 253.72 | 171.14 | 169.99 | 185.68 | 218.12 |
| Gross profit | 812.73 | 1,284.61 | 899.00 | 718.89 | 1,155.74 |
| EPS (Rs) | 2.65 | 3.65 | 3.17 | 1.66 | 2.17 |
Quarterly
results in details
| Sep' 22 | Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | |
|---|---|---|---|---|---|
| Other income | 68.39 | 82.08 | 196.41 | 86.00 | 378.99 |
| Stock adjustment | 45.72 | 191.66 | -178.71 | 179.30 | 46.11 |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 694.98 | 646.65 | 661.04 | 676.27 | 635.54 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,013.99 | 882.48 | 1,224.35 | 749.45 | 817.15 |
| Provisions made | - | - | - | - | - |
| Depreciation | 338.34 | 341.92 | 519.89 | 344.24 | 329.08 |
| Taxation | 167.59 | 251.07 | 55.38 | 111.26 | 1,045.87 |
| Net profit / loss | 367.21 | 506.08 | 439.73 | 229.62 | 300.21 |
| Extra ordinary item | 60.41 | -185.54 | 116.00 | -33.77 | 519.42 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 1,386.64 | 1,386.64 | 1,386.64 | 1,386.64 | 1,386.64 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 36.26 | 44.39 | 33.83 | 33.78 | 39.90 |
| GPM (%) | 28.81 | 40.44 | 32.39 | 28.65 | 40.23 |
| NPM (%) | 13.02 | 15.93 | 15.84 | 9.15 | 10.45 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis